EUVIMEDEUVIMED entdecken
Crossref

Role of Noninvasive Urinary Prothrombin Fragment 1 + 2 to Measure Blood Coagulation Indices and Dose of Acenocoumarol

Ashish Gupta iD, Deepak Kumar, Niharika Bharti, Sudeep Kumar, Shantanu Pande, Vikas Agarwal

Journal of Proteome Research · 2024

DOI: 10.1021/acs.jproteome.4c00462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteome Research, 2024. Verfasst von Ashish Gupta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Biomedical Research, SGPGIMS Campus, Raebareli Road, Lucknow 226014, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Anticoagulants, Prothrombin, Acenocoumarol, Peptide Fragments. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PF1 + 2 plasma levels are a crucial indicator for assessing anticoagulant action in individuals receiving anticoagulant treatment. Urine also has PF1 + 2 levels due to its molecular size. Hence, the present study aims to measure urinary prothrombin fragment 1 + 2 (uPF1 + 2) in patients taking anticoagulants in order to divulge a noninvasive surrogate marker of PT-INR of blood coagulopathy. A total of 205 people participated in the study: 104 patients on acenocoumarol (AC) and 101 healthy controls (HC). Clinical parameters, including PT-INR, urinary creatinine, etc., were measured in all subjects. To evaluate uPF1 + 2 in samples, MALDI-TOF-MS, Western blot analysis, and ELISA tests were used. The MALDI-TOF-MS results showed the presence of uPF1 + 2 in both AC and HC urine samples. The Western blot, ELISA experiment, and unpaired t test results displayed that the patients with AC had significantly increased levels of uPF1 + 2 compared to HC. A regression study showed a strong positive relation between blood-based PT-INR and uPF1 + 2. ROC validation also revealed the clinical efficacy of uPF1 + 2. For the goal to monitor anticoagulant medication, the present study highlights PF1 + 2, which describes the overall hemostatic capacity and might be utilized in addition to or instead of PT-INR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsProthrombinAcenocoumarolPeptide FragmentsHumansMaleFemaleMiddle AgedAgedBlood CoagulationAdultBiomarkersCase-Control StudiesEnzyme-Linked Immunosorbent AssayInternational Normalized RatioSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Stichwörter der Autor:innen

acenocoumarolcardiovascular diseasescoagulationinternational normalized ratioprothrombin fragment 1 + 2

Substanzen

AnticoagulantsProthrombinAcenocoumarolPeptide Fragmentsprothrombin fragment 1.2Biomarkers

Autor:innen und Institutionen

  • Centre of Biomedical Research, SGPGIMS Campus, Raebareli Road, Lucknow 226014, Uttar Pradesh, India.
  • Department of Cardiology, SGPGIMS, Lucknow 226014, Uttar Pradesh, India.
  • Department of Cardiovascular and Thoracic Surgery, SGPGIMS, Lucknow 226014, Uttar Pradesh, India.
  • Department of Immunology, SGPGIMS, Lucknow 226014, Uttar Pradesh, India.

ORCID-Profile: Ashish Gupta

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Gupta, A., Kumar, D., Bharti, N., Kumar, S., Pande, S., & Agarwal, V. (2024). Role of Noninvasive Urinary Prothrombin Fragment 1 + 2 to Measure Blood Coagulation Indices and Dose of Acenocoumarol. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.4c00462

Vancouver

Gupta A, Kumar D, Bharti N, Kumar S, Pande S, Agarwal V. Role of Noninvasive Urinary Prothrombin Fragment 1 + 2 to Measure Blood Coagulation Indices and Dose of Acenocoumarol. Journal of Proteome Research. 2024. doi:10.1021/acs.jproteome.4c00462

BibTeX
@article{Gupta2024,
  author = {Gupta, Ashish and Kumar, Deepak and Bharti, Niharika and Kumar, Sudeep and Pande, Shantanu and Agarwal, Vikas},
  title = {Role of Noninvasive Urinary Prothrombin Fragment 1 + 2 to Measure Blood Coagulation Indices and Dose of Acenocoumarol},
  journal = {Journal of Proteome Research},
  year = {2024},
  doi = {10.1021/acs.jproteome.4c00462}
}
Kostenlos starten →